Monthly Cumulative Number and Percent of Children <8 Months Who Received 1+ Monoclonal Antibody Doses by Jurisdiction, United States

RSV monoclonal antibody coverage for children 0 to 7 months is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. Monthly estimates shown are cumulative, reflecting all children who received an RSV monoclonal antibody from April 1 through the end of the reporting month.*,† Cumulative estimates include any historical data reported since the previous submission.

National estimates are not presented since not all U.S. jurisdictions are currently reporting their IIS data to CDC. Jurisdictions reporting data to CDC include U.S. states, some localities, and territories.